BrainChild Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $116M

  • Investors
  • 3

BrainChild Bio General Information

Description

Developer of cell therapies designed for tumors of the central nervous system. The company's platform incorporates multiplexed targeting of multiple tumor antigens to address tumor heterogeneity and reduce antigen escape, and potency-enhancing technologies intended to improve cell activity and persistence, enabling the healthcare industry to support repeat dosing and incorporate remote-control capabilities, with an initial focus on pediatric brain cancers such as diffuse intrinsic pontine glioma.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1150 Eastlake Avenue
  • Suite 900
  • Seattle, WA 98109
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1150 Eastlake Avenue
  • Suite 900
  • Seattle, WA 98109
  • United States
+1 (206)

BrainChild Bio Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BrainChild Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 08-Sep-2026 $116M Completed Clinical Trials - Phase 2
3. Grant 21-Jan-2025 Completed Clinical Trials - Phase 2
2. Corporate 05-Dec-2023 Completed Clinical Trials - Phase 2
1. Spin-Off 05-Dec-2023 Completed Clinical Trials - Phase 2
To view BrainChild Bio’s complete valuation and funding history, request access »

BrainChild Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrainChild Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
WRF Capital Corporate Venture Capital Minority
ScaleReady Corporation
Seattle Children's Hospital Corporation Minority
To view BrainChild Bio’s complete investors history, request access »

BrainChild Bio FAQs

  • When was BrainChild Bio founded?

    BrainChild Bio was founded in 2023.

  • Where is BrainChild Bio headquartered?

    BrainChild Bio is headquartered in Seattle, WA.

  • What is the size of BrainChild Bio?

    BrainChild Bio has 40 total employees.

  • What industry is BrainChild Bio in?

    BrainChild Bio’s primary industry is Drug Discovery.

  • Is BrainChild Bio a private or public company?

    BrainChild Bio is a Private company.

  • What is BrainChild Bio’s current revenue?

    The current revenue for BrainChild Bio is .

  • How much funding has BrainChild Bio raised over time?

    BrainChild Bio has raised $116M.

  • Who are BrainChild Bio’s investors?

    WRF Capital, ScaleReady, and Seattle Children's Hospital have invested in BrainChild Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process